Results 51 to 60 of about 9,596 (222)

Recurrent non‐traumatic idiopathic chylothorax: a diagnostic dilemma with therapeutic challenge

open access: yesRespirology Case Reports, 2020
Chylothorax is an uncommon pleural effusion characterized by the presence of chyle in the pleural space. Malignancy, trauma, and infections such as tuberculosis and filariasis can result in chylothorax. The chyle is an odourless and white liquid; however,
Rohit Vadala   +2 more
doaj   +1 more source

Resolution of Refractory Multifocal Atrial Tachycardia in Costello Syndrome Using Trametinib: A Case Supporting MEK Inhibitors as Targeted, Specific Antiarrhythmic

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Arrhythmias affect approximately half of patients with Costello syndrome (CS, OMIM # 218040), with non‐reentrant atrial tachycardia being the most common. This case describes an infant with Costello syndrome carrying the pathogenic HRAS c.34G>A (p.G12S) variant who developed early‐onset, drug‐refractory multifocal atrial tachycardia (MAT ...
Vanina Taliercio   +11 more
wiley   +1 more source

Direct Percutaneous Needle Puncture and Intrapulmonary Lymphatic Embolization for Treatment of Chylothorax in a Patient with Lymphoma

open access: yes대한영상의학회지, 2020
Lymphoma is a common cause of nontraumatic chylothorax. Clinical success rates of thoracic duct embolization are lower in patients with nontraumatic chylothorax compared to patients with traumatic chylothorax.
Lee Hwangbo   +3 more
doaj   +1 more source

Hodgkin's lymphoma in a milky way

open access: yesIndian Journal of Respiratory Care, 2022
Chylothorax refers to the accumulation of chyle in the pleural space. The most common cause of nontraumatic chylothorax is tuberculosis, malignancy, and congenital causes.
Hasna Erattengal, C Nandish
doaj   +1 more source

A rare case of membranous nephropathy complicated by chylothorax

open access: yesEuropean Journal of Case Reports in Internal Medicine
Background: Chylothorax can be classified into traumatic and nontraumatic based on the etiology. Nephrotic syndrome is a very rare cause of nontraumatic chylothorax in adults. Case presentation: A 66-year-old woman with membranous nephropathy who was non-
Abdelhadi Farouji   +5 more
doaj   +1 more source

Presentations and management of different causes of chylothorax in children: one medical center’s experience

open access: yesBioMedicine, 2017
Background: Chylothorax in children is a relatively rare cause of pleural effusion. However, it is usually a common complication of cardiothoracic operations like open-heart surgery.
Lin Chien-Heng   +2 more
doaj   +1 more source

Successful use of doxycycline pleurodesis in non-immune hydrops fetalis secondary to congenital chylothorax

open access: yesJournal of Pediatric Surgery Case Reports, 2018
Congenital chylothorax is a rare presentation of nonimmune hydrops fetalis (NIHF). We report a case of congenital chylothorax presenting as NIHF managed successfully with chemical pleurodesis.
Vilmaris Quinones Cardona, MD   +3 more
doaj   +1 more source

Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre‐Operative PD1 CheckpOint Blockade and Receptor Activator of NF‐κB Ligand (RANKL) Inhibition in Non‐Small Cell Lung Cancer (NSCLC)—A Phase 1B/2 Trial

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Expanding on the growing evidence for neoadjuvant immunotherapy in resectable non‐small cell lung cancer, this study explored neoadjuvant nivolumab ± denosumab. Two of the 10 treated patients achieved a pathological complete response. CD8 T‐cell infiltration correlated with pathological response, warranting ongoing translational research to understand ...
Elizabeth Ahern   +11 more
wiley   +1 more source

A Case of Chyloma after Esophagectomy with Respiratory Dysfunction [PDF]

open access: yes, 2006
We report a case of intractable chylothorax with chyloma after esophagectomy that demonstrated respiratory dysfunction. A 55-year-old man underwent thoracoscopically esophagectomy for esophageal cancer.
花村, 徹   +6 more
core   +1 more source

Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non‐Small Cell Lung Cancer

open access: yesCancer Science, EarlyView.
The flow of this trial and the treatment schedule of adjuvant chemotherapy with nedaplatin plus docetaxel for completely resected non‐small cell lung cancer (NSCLC) (A). The primary endpoint of this study was tolerability, assessed by the completion rate of the planned four chemotherapy cycles. As a result, it was 74.3%, exceeding that reported for the
Koji Teramoto   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy